Taisho Pharmaceutical Holdings Co., Ltd.
TAIPY · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $255,966,000 | $265,049,000 | $250,178,000 | $223,814,000 |
| Short-Term Investments | $200,000 | $7,219,000 | $4,017,000 | $14,089,000 |
| Receivables | $51,925,000 | $53,265,000 | $51,176,000 | $65,014,000 |
| Inventory | $53,331,000 | $44,891,000 | $46,383,000 | $43,369,000 |
| Other Curr. Assets | $14,458,000 | $8,440,000 | $5,977,000 | $9,337,000 |
| Total Curr. Assets | $375,880,000 | $378,864,000 | $357,731,000 | $355,623,000 |
| Property Plant & Equip (Net) | $141,170,000 | $119,291,000 | $113,194,000 | $112,555,000 |
| Goodwill | $128,051,000 | $125,769,000 | $128,612,000 | $169,862,000 |
| Intangibles | $110,441,000 | $87,290,000 | $87,920,000 | $40,118,000 |
| Long-Term Investments | $163,216,000 | $146,405,000 | $164,299,000 | $143,386,000 |
| Tax Assets | $6,761,000 | $9,508,000 | $8,892,000 | $11,134,000 |
| Other NC Assets | $15,968,000 | $21,028,000 | $16,271,000 | $20,369,000 |
| Total NC Assets | $565,607,000 | $509,291,000 | $519,188,000 | $497,424,000 |
| Other Assets | $3,000 | $4,000 | $4,000 | $4,000 |
| Total Assets | $941,490,000 | $888,159,000 | $876,923,000 | $853,051,000 |
| Liabilities | – | – | – | – |
| Payables | $17,001,000 | $15,101,000 | $14,672,000 | $18,045,000 |
| Short-Term Debt | $0 | $2,289,000 | $1,587,000 | $1,814,000 |
| Tax Payable | $1,889,000 | $3,579,000 | $3,275,000 | $5,414,000 |
| Deferred Revenue | $0 | $246,000 | -$1,587,000 | -$1,814,000 |
| Other Curr. Liab. | $54,888,000 | $41,308,000 | $38,132,000 | $41,183,000 |
| Total Curr. Liab. | $73,778,000 | $62,277,000 | $57,666,000 | $66,456,000 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $350,000 | $550,000 | $0 | $0 |
| Deferred Tax Liab, NC | $32,801,000 | $29,162,000 | $32,747,000 | $16,943,000 |
| Other NC Liab. | $26,014,000 | $28,763,000 | $28,106,000 | $27,946,000 |
| Total NC Liab. | $59,165,000 | $57,925,000 | $60,853,000 | $44,889,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $132,943,000 | $120,202,000 | $118,519,000 | $111,345,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $30,000,000 | $30,000,000 | $30,000,000 | $30,000,000 |
| Retained Earnings | $713,776,000 | $702,984,000 | $703,036,000 | $699,412,000 |
| AOCI | $63,853,000 | $36,198,000 | $31,907,000 | $17,378,000 |
| Other Equity | -$21,062,000 | -$21,033,000 | -$35,438,000 | -$16,147,000 |
| Total Equity | $786,567,000 | $748,151,000 | $729,504,000 | $712,076,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $22,776,000 | $19,806,000 | $28,900,000 | $29,630,000 |
| Total Liab. & Tot. Equity | $941,490,000 | $888,159,000 | $876,923,000 | $853,051,000 |
| Net Debt | -$255,966,000 | -$262,760,000 | -$248,591,000 | -$222,000,000 |